Use of hearing aids may reduce the risk of dementia in people with hearing difficulties, according to a new UK Biobank study published in @TheLancetPH #AEScienceWatch
https://www.alzheimer-europe.org/news/timely-use-hearing-aids-may-reduce-risk-dementia-people-hearing-difficulties-according-uk

US-based health economics study reveals the cost-effectiveness of non-pharmacological interventions for people with #dementia and their caregivers #AEScienceWatch
https://www.alzheimer-europe.org/news/american-health-economics-study-reveals-cost-effectiveness-non-pharmacological-interventions

Analysis of Rotterdam study data in @GreenJournal shows that older adults with low bone mineral density may be at higher risk of developing dementia #AEScienceWatch
https://www.alzheimer-europe.org/news/analysis-rotterdam-study-shows-people-low-bone-mineral-density-may-have-higher-risk-developing

): .@CochraneDCIG review performs systematic analysis of studies on cognitive stimulation, finding small benefits for people with mild-to-moderate dementia participating in regular group sessions #AEScienceWatch
https://www.alzheimer-europe.org/news/cochrane-review-analyses-studies-cognitive-stimulation-finding-small-benefits-people-mild

Expert consensus group including our Executive Director, @JeanGeorgesAE, prioritises outcome measures for #Alzheimers disease, publishing their findings in @alzdemjournals #AEScienceWatch
https://www.alzheimer-europe.org/news/expert-consensus-group-prioritises-outcome-measures-alzheimers-disease-publishing-their

New research published in @PNASNews describes a novel #ArtificialIntelligence based tool that estimates brain age and could predict cognitive decline, based on images from #brain MRI scans #AEScienceWatch
https://www.alzheimer-europe.org/news/researchers-develop-new-ai-based-method-estimates-brain-age-and-predicts-cognitive-decline

Longitudinal study of inherited #Alzheimer’s disease in @Brain1878 identifies blood-based #biomarkers that may be able to detect AD pathology long before symptoms occur #AEScienceWatch
https://www.alzheimer-europe.org/news/clinical-study-identifies-blood-based-biomarkers-could-detect-ad-long-symptoms-occur

RT @AlzheimerEurope
The @US_FDA has granted accelerated approval of #lecanemab, for the treatment of mild cognitive impairment or mild #dementia in #Alzheimers disease #AEScienceWatch
https://www.alzheimer-europe.org/news/us-fda-grants-accelerated-approval-lecanemab-treatment-mild-cognitive-impairment-or-mild